# Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia

> **NCT03197064** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 11 (actual)

## Conditions studied

- Postoperative Nausea

## Interventions

- **DRUG:** Fosaprepitant 150 mg

## Key facts

- **NCT ID:** NCT03197064
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-01
- **Primary completion:** 2020-01-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03197064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03197064, "Effect of Fosaprepitant on Motor Evoked and Somatosensory Evoked Potentials Under General Anesthesia". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03197064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*